Insulet Corporation (PODD) stock analysis
PODD · Insulet Corporation
Latest recorded price: USD 145.29
Model-estimated fair value: USD 114.95. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $145.29, PODD trades 26.4% above the model's base-case value of $114.95. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $85.30 in the conservative case and $150.59 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 27.5%, free cash flow margin 13.9%, ROIC 19.8%. The model does not flag any risk signals for this company.